![](/img/cover-not-exists.png)
AB0373 Dose Response Modeling Is A Useful Tool To Determine Doses for Phase 3: Experience from Olokizumab
Reeve, R., Krotkova, A., Weilert, D., Fatenejad, S.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.2066
Date:
June, 2016
File:
PDF, 108 KB
english, 2016